Nvidia Nemotron 3 Ultra Hits 10x Cost Edge as NVDA Climbs to $203

Nvidia shares reached $203.28, up 3.22%, after its open-source Nemotron 3 Ultra model delivered task parity with closed competitors at 10x lower inference costs. The three-week product surge that began June 17 with self-training ENPIRE robots expanded through XR AI beta, BioNeMo toolkit adoption by 50+ firms, the AI Factory revenue-sharing model, and culminated July 7 with AI Aerial delivering up to 3x spectral-efficiency gains in RAN trials. Fiscal Q1 revenue reached $81.6 billion, up 85%, while partnerships with Corning and Space-1 initiatives broadened the ecosystem; Michael Burry’s expanded short position has not halted the advance to a $4.82 trillion valuation.